SCHEMBL14385066

SCHEMBL14385066

Cc1ccc2cc3c(C(N)=O)n[nH]c3cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K4 P45985 4/20 0.49
▸ MAPK1 P28482 3/20 0.49
▸ MAPKAPK3 Q16644 3/20 0.49
▸ MAPK6 Q16659 3/20 0.49
▸ MAPKAPK2 P49137 2/20 0.49
▸ MAPKAPK5 Q8IW41 2/20 0.49
▸ JAK2 O60674 1/20 0.48
▸ JAK1 P23458 1/20 0.48
▸ TYK2 P29597 1/20 0.48
▸ JAK3 P52333 1/20 0.48
▸ KCNMA1 Q12791 1/20 0.41
▸ FLT3 P36888 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ IKBKB O14920 1/20 0.40
▸ MAP4K1 Q92918 1/20 0.40
▸ ABL1 P00519 2/20 0.40
▸ BCR P11274 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15541582 0.86 JAK2 (0.53) MAP2K4MAPK1MAPKAPK3MAPK6MAPKAPK2
SCHEMBL15942818 0.83 MAP2K4 (0.62) MAP2K4MAPK1MAPKAPK3MAPK6MAPKAPK2
SCHEMBL14346062 0.82 LRRK2 (0.47) MAP2K4JAK2JAK1TYK2JAK3
SCHEMBL14368882 0.82 JAK2 (0.51) JAK2JAK1TYK2JAK3ALDH1A1
SCHEMBL15601766 0.82 PDPK1 (0.47) JAK2JAK3ALDH1A1LMNAPOLB
SCHEMBL13069602 0.74 JAK2 (0.51) MAPK1JAK2JAK1TYK2JAK3
SCHEMBL28258656 0.73 CHEK1 (0.53) MAP2K4MAPK1MAPKAPK3MAPK6MAPKAPK2
SCHEMBL8877902 0.72 JAK1 (0.65) JAK2JAK1TYK2JAK3ALDH1A1
SCHEMBL12090187 0.72 MAPK1 (0.50) MAP2K4MAPK1MAPKAPK3MAPK6FLT3
SCHEMBL12059754 0.71 JAK1 (0.51) MAP2K4MAPK1MAPKAPK3MAPK6MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150290200-A1 INTRACELLULAR KINASE INHIBITORS PHARMACYCLICS INC (US) 2015-10-15 — — US disclosed
US-20140080833-A1 INTRACELLULAR KINASE INHIBITORS MANNKIND CORPORATION (US) 2014-03-20 — — US disclosed
WO-2007136790-A2 INTRACELLULAR KINASE INHIBITORS MANNKIND CORPORATION (US) 2007-11-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150290200-A1 INTRACELLULAR KINASE INHIBITORS PI4KB, BTK, LTK MAP2K4 200/4885MAPK1 216/4885MAPKAPK3 106/4885
US-20140080833-A1 INTRACELLULAR KINASE INHIBITORS PI4KB, BTK, LTK MAP2K4 200/4885MAPK1 216/4885MAPKAPK3 106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback